Traditional drug development and discovery has not kept pace with threats from emerging
and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV …

Evidence shows that neutrophils can protect the host against pathogens in multiple ways,
including the formation and release of neutrophil extracellular traps (NETs). NETs are web …

Abstract Purpose of Review The rapid spread of virus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency. Symptoms of this …

Hydroxychloroquine, initially used as an antimalarial, is used as an immunomodulatory and
anti-inflammatory agent for the management of autoimmune and rheumatic diseases such …

Active neutrophils participate in innate and adaptive immune responses through various
mechanisms, one of the most important of which is the formation and release of neutrophil …

The current coronavirus pandemic, COVID-19, is the third outbreak of disease caused by the
coronavirus family, after Severe Acute Respiratory Syndrome and Middle East Respiratory …

The entire world is struggling to control the spread of coronavirus (COVID‐19) as there are
no proper drugs for treating the disease. Under clinical trials, some of the repurposed …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to sweep the
world, causing infection of millions and death of hundreds of thousands. The respiratory …

The SARS-CoV-2 spread quickly across the globe. The World Health Organization (WHO)
on March 11 declared COVID-19 a pandemic. The mortality rate, hospital disorders and …

Objectives Patients with inflammatory rheumatic diseases (IRD) infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) may be at risk to develop a severe …